
Alcon Posts Q2 2025 Results, Unveils Tryptyr Launch and Plans STAAR Surgical Acquisition
Alcon Delivers Solid Q2 2025 Results, Launches Tryptyr, and Announces Strategic Acquisition of STAAR Surgical Alcon (SIX/NYSE: ALC), the global leader in eye care, reported its financial results for the second quarter and first half of 2025, ending June 30.…











